Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating hydroxychloroquine for ulcerative colitis in African American and Hispanic participants; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (Plaquenil) (hydroxychloroquine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Ulcerative Colitis (Disorder) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING